NBE Therapeutics
1 follower
‌
NBE-Therapeutics is developing best-in-class cancer therapies to increase survival and improve quality of life for cancer patients worldwide. The company’s next-generation immune-stimulatory therapies are based on a proprietary, highly differentiated Antibody-Drug Conjugate (ADC) platform. This best... Read more
Industries
Headquarters
Employees
Links
Org chart
Jean Engela
CEO
Jean Engela
Collapse
Flavio Solca
Chief Scientific Officer
Gerd Munzert
Chief Clinical Officer
Carl Deutsch, PhD, MBA
Chief Scientific Officer
Cornelia Baumgartner- Diolaiuti
Consulting Clinical Operations Manager
Giuliano Bellapadrona
Associate Director, Global CMC
Hüseyin Birogul
Head of Conjugation
Ina Hellmann
Program Manager Early Development
Marco Meier
Head of in vivo unit
Mariarosa Spina Horn
Human Resources Business Partner
Ulrike Fiedler
Senior Director Program Management and Pipeline Innovation
Florian Durante
Financial Controller
Similar companies
ETH Zürich
5 followers
Forge Biologics
2 followers
Molecular Partners
2 followers
Expansion Therapeutics
2 followers
Kyverna Therapeutics
5 followers
Neuron23
1 follower
Slingshot Biosciences
1 follower
Cellares
2 followers
Sano Genetics
2 followers
Thermo Fisher Scientific
149 followers
Gilead Sciences
121 followers
Discover companies